SALBUTAMOL

Ventolin, Respax

Reviewed by Dr Simon Rowley, Dr Innes Asher, Dorothy Cooper
September 1996
Dose for Hyperkalaemia revised July 2003 (Carl Kuschel)
Dose and Pharmacology Newborn Drug Protocol Index Newborn Services Home Page

Management of Administration of Nebulised Salbutamol

Description

Prescription

Administration

Nebulised

  1. Ensure nebuliser is in working order.
  2. Salbutamol is diluted in NS. Make up to 4ml.
  3. Salbutamol may be administered with sodium cromoglycate or ipratropium, if administration times coincide. It is not recommended to mix sodium cromoglycate (Intal) and ipratropium nebuliser solutions. Ensure total volume is made up to 4 ml with NS. Mix immediately prior to use. Discard if any turbidity or precipitation occurs.
  4. Nebulisation via a mask:
  1. Nebulisation via a ventilator circuit:
  1. Soaking in sodium hypochlorite solution is NOT recommended. Separate pieces. Rinse, dry on paper towel. Store dry in covered container.
  2. Change nebuliser weekly and PRN.

Observation and Documentation

  1. Assess for signs of adverse effects.
  2. Monitor apex beat, rate and rhythm regularly. Apex beat must be taken immediately, prior to administration (preferably an undisturbed rate). If apex beat is >180/min withhold medication and notify doctor / NS-ANP immediately.
  3. Monitor SaO2 during administration of salbutamol and for up to 30 minutes after.
  4. Continue to provide oxygen and ventilatory support as appropriate.
  5. Ensure ventilator pressures remain unchanged during nebulisation.
  6. Document patient response to therapy.

Storage

Selected References

1 Seligman M. Bronchodilators. In: Essentials of critical care pharmacology. Chernow B (ed) Baltimore, Williams & Wilkins 1989, page 207-21.
2 Rau JL. Respiratory therapy pharmacology. Chicago, Year Book Medical 1984, p73-92.
3 Wilkie RA, Bryan MH. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr 1987; 111:278-82.
4 Denjean A, Guimaraef H, Migdal M, Miramand JL, Denham M, Gaultier C. Dose-related bronchodilator response to aerosolized salbutamol (albuterol) in ventilator-dependent premature infants. J Pediatr 1992; 120:974-9.
5 Auckland Regional Advisory Service. Guidelines for nebuliser use in hospital. Rationale for recommendations July 1994.
6 McClare RJ, Prasad VK, Bracklebank JT. Treatment of hyperkalaemia using intravenous and nebulised salbutamol. Arch Dis Child, 1994; 70:126-8.
7 The Northern Neonatal Network.  Neonatal Formulary (3rd Ed), BMJ Publishing 2000